IL-32 is a molecular marker of a host defense network in human tuberculosis

Science Translational Medicine

Volumn 6, Issue 250, 2014, Pages

  Montoya, Dennis ^a   Inkeles, Megan S ^b   Liu, Phillip T ^a   Realegeno, Susan ^a,b   Teles, Rosane M B ^a   Vaidya, Poorva ^a   Munoz, Marcos A ^a   Schenk, Mirjam ^a   Swindell, William R ^c   Chun, Rene ^a   Zavala, Kathryn ^a   Hewison, Martin ^a   Adams, John S ^a   Horvath, Steve ^a,d   Pellegrini, Matteo ^b   Bloom, Barry R ^e   Modlin, Robert L ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GAMMA INTERFERON; INTERLEUKIN 15; INTERLEUKIN 32; VITAMIN D; ANTIMICROBIAL CATIONIC PEPTIDE; IL32 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE;

ANTIBIOTIC THERAPY; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE RESPONSE; GENE EXPRESSION PROFILING; GENE STRUCTURE; HOST RESISTANCE; HUMAN; HUMAN CELL; LATENT TUBERCULOSIS; MACROPHAGE; MAJOR CLINICAL STUDY; MYCOBACTERIUM TUBERCULOSIS; DRUG EFFECTS; GENETICS; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PATHOLOGY; PHYSIOLOGY; TUBERCULOSIS;

ANTIMICROBIAL CATIONIC PEPTIDES; BIOMARKERS; CELL DIFFERENTIATION; GENE EXPRESSION PROFILING; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-15; INTERLEUKINS; MACROPHAGES; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS; VITAMIN D;

EID: 84907412761     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3009546     Document Type: Article

References (64)

1. WHO Global TB Report, http://www.who.int/tb/publications/factsheet-global.pdf (2012).
2. E. L. Corbett, C. J. Watt, N. Walker, D. Maher, B. G. Williams, M. C. Raviglione, C. Dye, The growing burden of tuberculosis: Global trends and interactions with the HIV epidemic. Arch. Intern. Med. 163, 1009-1021 (2003).
3. C. Dye, S. Scheele, P. Dolin, V. Pathania, M. C. Raviglione, for the WHO Global Surveillance and Monitoring Project, Global burden of tuberculosis: Estimated incidence, prevalence, and mortality by country. JAMA 282, 677-686 (1999).
4. N. R. Gandhi, A. Moll, A. W. Sturm, R. Pawinski, T. Govender, U. Lalloo, K. Zeller, J. Andrews, G. Friedland, Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 368, 1575-1580 (2006).
5. M. P. Berry, C. M. Graham, F.W. McNab, Z. Xu, S. A. Bloch, T. Oni, K. A. Wilkinson, R. Banchereau, J. Skinner, R. J. Wilkinson, C. Quinn, D. Blankenship, R. Dhawan, J. J. Cush, A. Mejias, O. Ramilo, O. M. Kon, V. Pascual, J. Banchereau, D. Chaussabel, A. O'Garra, An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466, 973-977 (2010).
6. J. Maertzdorf, J. Weiner III, H. J. Mollenkopf; TBornotTB Network, T. Bauer, A. Prasse, J. Müller-Quernheim, S. H. Kaufmann, Common patterns and disease-related signatures in tuberculosis and sarcoidosis. Proc. Natl. Acad. Sci. U.S.A. 109, 7853-7858 (2012).
7. T. H. Ottenhoff, R. H. Dass, N. Yang, M. M. Zhang, H. E. Wong, E. Sahiratmadja, C. C. Khor, B. Alisjahbana, R. van Crevel, S. Marzuki, M. Seielstad, E. van de Vosse, M. L. Hibberd, Genomewide expression profiling identifies type 1 interferon response pathways in active tuberculosis. PLOS One 7, e45839 (2012).
8. C. I. Bloom, C. M. Graham, M. P. Berry, K. A. Wilkinson, T. Oni, F. Rozakeas, Z. Xu, J. Rossello-Urgell, D. Chaussabel, J. Banchereau, V. Pascual, M. Lipman, R. J. Wilkinson, A. O'Garra, Detectable changes in the blood transcriptome are present after two weeks of antituberculosis therapy. PLOS One 7, e46191 (2012).
9. R. M. Teles, T. G. Graeber, S. R. Krutzik, D. Montoya, M. Schenk, D. J. Lee, E. Komisopoulou, K. Kelly-Scumpia, R. Chun, S. S. Iyer, E. N. Sarno, T. H. Rea, M.Hewison, J. S. Adams, S. J. Popper, D. A. Relman, S. Stenger, B. R. Bloom, G. Cheng, R. L. Modlin, Type I interferon suppresses type II interferon-triggered human anti-mycobacterial responses. Science 339, 1448-1453 (2013).
10. S. R. Krutzik, M. Hewison, P. T. Liu, J. A. Robles, S. Stenger, J. S. Adams, R. L. Modlin, IL-15 links TLR2/1-induced macrophage differentiation to the vitamin D-dependent antimicrobial pathway. J. Immunol. 181, 7115-7120 (2008).
11. D.Montoya, D. Cruz, R. M. Teles, D. J. Lee, M. T. Ochoa, S. R. Krutzik, R. Chun, M. Schenk, X. Zhang, B. G. Ferguson, A. E. Burdick, E. N. Sarno, T. H. Rea, M. Hewison, J. S. Adams, G. Cheng, R. L. Modlin, Divergence of macrophage phagocytic and antimicrobial programs in leprosy. Cell Host Microbe 6, 343-353 (2009).
12. K. Edfeldt, P. T. Liu, R. Chun, M. Fabri, M. Schenk, M. Wheelwright, C. Keegan, S. R. Krutzik, J. S. Adams, M. Hewison, R. L. Modlin, T-cell cytokines differentially control human monocyte antimicrobial responses by regulating vitamin D metabolism. Proc. Natl. Acad. Sci. U.S.A. 107, 22593-22598 (2010).
13. W. Huang da, B. T. Sherman, R. A. Lempicki, Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44-57 (2009).
14. D. W. Huang, B. T. Sherman, R. A. Lempicki, Bioinformatics enrichment tools: Paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 37, 1 -13 (2009).
15. M. G. Netea, T. Azam, E. C. Lewis, L. A. Joosten, M. Wang, D. Langenberg, X. Meng, E. D. Chan, D. Y. Yoon, T. Ottenhoff, S. H. Kim, C. A.Dinarello, Mycobacterium tuberculosis induces interleukin-32 production through a caspase-1/IL-18/interferon-γ-dependent mechanism. PLOS Med. 3, e277 (2006).
16. X. Bai, S. H. Kim, T. Azam, M. T. McGibney, H. Huang, C. A. Dinarello, E. D. Chan, IL-32 is a host protective cytokine against Mycobacterium tuberculosis in differentiated THP-1 human macrophages. J. Immunol. 184, 3830-3840 (2010).
17. M. Schenk, S. R. Krutzik, P. A. Sieling, D. J. Lee, R. M. Teles, M. T. Ochoa, E. Komisopoulou, E. N. Sarno, T. H. Rea, T. G. Graeber, S. Kim, G. Cheng, R. L. Modlin, NOD2 triggers an interleukin-32-dependent human dendritic cell program in leprosy. Nat. Med. 18, 555-563 (2012).
18. H. E. Barksby, C. J. Nile, K. M. Jaedicke, J. J. Taylor, P. M. Preshaw, Differential expression of immunoregulatory genes in monocytes in response to Porphyromonas gingivalis and Escherichia coli lipopolysaccharide. Clin. Exp. Immunol. 156, 479-487 (2009).
19. P. T. Liu, S. Stenger, H. Li, L. Wenzel, B. H. Tan, S. R. Krutzik, M. T. Ochoa, J. Schauber, K. Wu, C. Meinken, D. L. Kamen, M.Wagner, R. Bals, A. Steinmeyer, U. Zügel, R. L. Gallo, D. Eisenberg, M. Hewison, B. W. Hollis, J. S. Adams, B. R. Bloom, R. L. Modlin, Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311, 1770-1773 (2006).
20. G. M. Klug-Micu, S. Stenger, A. Sommer, P. T. Liu, S. R. Krutzik, R. L. Modlin, M. Fabri, CD40 ligand and interferon-g induce an antimicrobial response against Mycobacterium tuberculosis in human monocytes. Immunology 139, 121-128 (2013).
21. C. S. Yang, D. M. Shin, K. H. Kim, Z. W. Lee, C. H. Lee, S. G. Park, Y. S. Bae, E. K. Jo, NADPH oxidase 2 interaction with TLR2 is required for efficient innate immune responses to mycobacteria via cathelicidin expression. J. Immunol. 182, 3696-3705 (2009).
22. 3is mediated by a lack of ligand-induced vitamin D receptor interaction with coactivators. J. Biol. Chem. 275, 16506-16512 (2000).
23. M. Fabri, S. Stenger, D. M. Shin, J. M. Yuk, P. T. Liu, S. Realegeno, H. M. Lee, S. R. Krutzik, M. Schenk, P. A. Sieling, R. Teles, D. Montoya, S. S. Iyer, H. Bruns, D. M. Lewinsohn, B. W. Hollis, M. Hewison, J. S. Adams, A. Steinmeyer, U. Zügel, G. Cheng, E. K. Jo, B. R. Bloom, R. L. Modlin, Vitamin D is required for IFN-g-mediated antimicrobial activity of human macrophages. Sci. Transl. Med. 3, 104ra102 (2011).
24. M. Kaforou, V. J. Wright, T. Oni, N. French, S. T. Anderson, N. Bangani, C. M. Banwell, A. J. Brent, A. C. Crampin, H. M. Dockrell, B. Eley, R. S. Heyderman, M. L. Hibberd, F. Kern, P. R. Langford, L. Ling, M. Mendelson, T. H. Ottenhoff, F. Zgambo, R. J. Wilkinson, L. J. Coin, M. Levin, Detection of tuberculosis in HIV-infected and -uninfected African adults using whole blood RNA expression signatures: A case-control study. PLOS Med. 10, e1001538 (2013).
25. L. Guo, E. K. Lobenhofer, C. Wang, R. Shippy, S. C. Harris, L. Zhang, N. Mei, T. Chen, D. Herman, F. M. Goodsaid, P. Hurban, K. L. Phillips, J. Xu, X. Deng, Y. A. Sun, W. Tong, Y. P. Dragan, L. Shi, Rat toxicogenomic study reveals analytical consistency across microarray platforms. Nat. Biotechnol. 24, 1162-1169 (2006).
26. +T cells. Eur. J. Immunol. 40, 279-290 (2010).
27. M. Matsumiya, E. Stylianou, K. Griffiths, Z. Lang, J. Meyer, S. A. Harris, R. Rowland, A. M. Minassian, A. A. Pathan, H. Fletcher, H. McShane, Roles for Treg expansion and HMGB1 signaling through the TLR1-2-6 axis in determining the magnitude of the antigen-specific immune response to MVA85A. PLOS One 8, e67922 (2013).
28. M. D. Tameris, M. Hatherill, B. S. Landry, T. J. Scriba, M. A. Snowden, S. Lockhart, J. E. Shea, J. B. McClain, G. D. Hussey, W. A. Hanekom, H. Mahomed, H. McShane; MVA85A 020 Trial Study Team, Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: A randomised, placebo-controlled phase 2b trial. Lancet 381, 1021-1028 (2013).
29. R. S. Wallis, M. Pai, D. Menzies, T. M. Doherty, G. Walzl, M. D. Perkins, A. Zumla, Biomarkers and diagnostics for tuberculosis: Progress, needs, and translation into practice. Lancet 375, 1920-1937 (2010).
30. A. R. Martineau, K. A. Wilkinson, S. M. Newton, R. A. Floto, A. W. Norman, K. Skolimowska, R. N. Davidson, O. E. Sørensen, B. Kampmann, C. J. Griffiths, R. J. Wilkinson, IFN-γ- and TNF-independent vitamin D-inducible human suppression of mycobacteria: The role of cathelicidin LL-37. J. Immunol. 178, 7190-7198 (2007).
31. J. M. Yuk, D. M. Shin, H. M. Lee, C. S. Yang, H. S. Jin, K. K. Kim, Z. W. Lee, S. H. Lee, J. M. Kim, E. K. Jo, Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell Host Microbe 6, 231-243 (2009).
32. D. M. Shin, J. M. Yuk, H. M. Lee, S. H. Lee, J.W. Son, C. V. Harding, J. M. Kim, R. L. Modlin, E. K. Jo, Mycobacterial lipoprotein activates autophagy via TLR2/1/CD14 and a functional vitamin D receptor signalling. Cell Microbiol. 12, 1648-1665 (2010).
33. S. R. Krutzik, B. Tan, H. Li, M. T. Ochoa, P. T. Liu, S. E. Sharfstein, T. G. Graeber, P. A. Sieling, Y. J. Liu, T. H. Rea, B. R. Bloom, R. L. Modlin, TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells. Nat. Med. 11, 653-660 (2005).
34. M. G. Netea, E. C. Lewis, T. Azam, L. A. Joosten, J. Jaekal, S. Y. Bae, C. A. Dinarello, S. H. Kim, Interleukin-32 induces the differentiation of monocytes into macrophage-like cells. Proc. Natl. Acad. Sci. U.S.A 105, 3515-3520 (2008).
35. M. F. Nold, C. A. Nold-Petry, G. B. Pott, J. A. Zepp, M. T. Saavedra, S. H. Kim, C. A. Dinarello, Endogenous IL-32 controls cytokine and HIV-1 production. J. Immunol. 181, 557-565 (2008).
36. W. Li, Y. Liu, M. M. Mukhtar, R. Gong, Y. Pan, S. T. Rasool, Y. Gao, L. Kang, Q.Hao, G. Peng, Y. Chen, X. Chen, J. Wu, Y. Zhu, Activation of interleukin-32 pro-inflammatory pathway in response to influenza A virus infection. PLOS One 3, e1985 (2008).
37. L. A. Joosten, M. G. Netea, S. H. Kim, D. Y. Yoon, B. Oppers-Walgreen, T. R. Radstake, P. Barrera, F. A. van de Loo, C. A. Dinarello, W. B. van den Berg, IL-32, a proinflammatory cytokine in rheumatoid arthritis. Proc. Natl. Acad. Sci. U.S.A. 103, 3298-3303 (2006).
38. M. Shioya, A. Nishida, Y. Yagi, A. Ogawa, T. Tsujikawa, S. Kim-Mitsuyama, A. Takayanagi, N. Shimizu, Y. Fujiyama, A. Andoh, Epithelial overexpression of interleukin-32a in inflammatory bowel disease. Clin. Exp. Immunol. 149, 480-486 (2007).
39. A. M. Marcondes, A. J. Mhyre, D. L. Stirewalt, S. H. Kim, C. A. Dinarello, H. J. Deeg, Dysregulation of IL-32 in myelodysplastic syndrome and chronic myelomonocytic leukemia modulates apoptosis and impairs NK function. Proc. Natl. Acad. Sci. U.S.A. 105, 2865-2870 (2008).
40. J. S. Adams, S. Ren, P. T. Liu, R. F. Chun, V. Lagishetty, A. F. Gombart, N. Borregaard, R. L. Modlin, M. Hewison, Vitamin d-directed rheostatic regulation of monocyte antibacterial responses. J. Immunol. 182, 4289-4295 (2009).
41. A. R. Martineau, R. J. Wilkinson, K. A. Wilkinson, S. M. Newton, B. Kampmann, B. M. Hall, G. E. Packe, R. N. Davidson, S. M. Eldridge, Z. J. Maunsell, S. J. Rainbow, J. L. Berry, C. J. Griffiths, A single dose of vitamin D enhances immunity to mycobacteria. Am. J. Respir. Crit. Care Med. 176, 208-213 (2007).
42. A. R. Martineau, P. M. Timms, G. H. Bothamley, Y. Hanifa, K. Islam, A. P. Claxton, G. E. Packe, J. C. Moore-Gillon, M. Darmalingam, R. N. Davidson, H. J. Milburn, L. V. Baker, R. D. Barker, N. J. Woodward, T. R. Venton, K. E. Barnes, C. J. Mullett, A. K. Coussens, C. M. Rutterford, C. A. Mein, G. R. Davies, R. J. Wilkinson, V. Nikolayevskyy, F. A. Drobniewski, S. M. Eldridge, C. J. Griffiths, High-dose vitamin D3 during intensive-phase antimicrobial treatment of pulmonary tuberculosis: A double-blind randomised controlled trial. Lancet 377, 242-250 (2011).
43. E. A. Miller, J. D. Ernst, Anti-TNF immunotherapy and tuberculosis reactivation: Another mechanism revealed. J. Clin. Invest. 119, 1079-1082 (2009).
44. +T cells in vitro. Immunology 87, 339-342 (1996).
45. J. S. Tan, D. H. Canaday, W. H. Boom, K. N. Balaji, S. K. Schwander, E. A. Rich, Human alveolar T lymphocyte responses to Mycobacterium tuberculosis antigens: Role for CD4+ and CD8+ cytotoxic T cells and relative resistance of alveolar macrophages to lysis. J. Immunol. 159, 290-297 (1997).
46. +T cells. J. Exp. Med. 196, 1473-1481 (2002).
47. S. Stenger, R. J. Mazzaccaro, K. Uyemura, S. Cho, P. F. Barnes, J. P. Rosat, A. Sette, M. B. Brenner, S. A. Porcelli, B. R. Bloom, R. L. Modlin, Differential effects of cytolytic T cell subsets on intracellular infection. Science 276, 1684-1687 (1997).
48. S. Stenger, D. A. Hanson, R. Teitelbaum, P. Dewan, K. R. Niazi, C. J. Froelich, T. Ganz, S. Thoma-Uszynski, A. Melián, C. Bogdan, S. A. Porcelli, B. R. Bloom, A. M. Krensky, R. L. Modlin, An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 282, 121-125 (1998).
49. C. Paludan, D. Schmid, M. Landthaler, M. Vockerodt, D. Kube, T. Tuschl, C. Münz, Endogenous MHC class II processing of a viral nuclear antigen after autophagy. Science 307, 593-596 (2005).
50. L. English, M. Chemali, J. Duron, C. Rondeau, A. Laplante, D. Gingras, D. Alexander, D. Leib, C. Norbury, R. Lippé, M. Desjardins, Autophagy enhances the presentation of endogenous viral antigens on MHC class I molecules during HSV-1 infection. Nat. Immunol. 10, 480-487 (2009).
51. J. Wang, B. Yang, Y. Hu, Y. Zheng, H. Zhou, Y. Wang, Y. Ma, K. Mao, L. Yang, G. Lin, Y. Ji, X. Wu, B. Sun, Negative regulation of Nmi on virus-triggered type I IFN production by targeting IRF7. J. Immunol. 191, 3393-3399 (2013).
52. Y. J. Zhang, M. C. Reddy, T. R. Ioerger, A. C. Rothchild, V. Dartois, B. M. Schuster, A. Trauner, D. Wallis, S. Galaviz, C. Huttenhower, J. C. Sacchettini, S. M. Behar, E. J. Rubin, Tryptophan biosynthesis protects mycobacteria from CD4 T-cell-mediated killing. Cell 155, 1296-1308 (2013).
53. D. Cruz, A. D. Watson, C. S. Miller, D. Montoya, M. T. Ochoa, P. A. Sieling, M. A. Gutierrez, M. Navab, S. T. Reddy, J. L. Witztum, A. M. Fogelman, T. H. Rea, D. Eisenberg, J. Berliner, R. L. Modlin, Host-derived oxidized phospholipids and HDL regulate innate immunity in human leprosy. J. Clin. Invest. 118, 2917-2928 (2008).
54. D. G. Russell, P. J. Cardona, M. J. Kim, S. Allain, F. Altare, Foamy macrophages and the progression of the human tuberculosis granuloma. Nat. Immunol. 10, 943-948 (2009).
55. M. J. Kim, H. C. Wainwright, M. Locketz, L. G. Bekker, G. B. Walther, C. Dittrich, A. Visser,W. Wang, F. F. Hsu, U. Wiehart, L. Tsenova, G. Kaplan, D. G. Russell, Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism. EMBO Mol. Med. 2, 258-274 (2010).
56. Fifteen year follow up of trial of BCG vaccines in south India for tuberculosis prevention. Tuberculosis Research Centre (ICMR), Chennai. Ind. J. Med. Res. 110, 56-69 (1999).
57. M. Frick, The Tubeculosis Vaccines Pipelines; http://www.pipelineport.org/2013/tb-vaccine (2013).
58. P. Langfelder, S. Horvath, WGCNA: An R package for weighted correlation network analysis. BMC Bioinformatics 9, 559 (2008).
59. Z. Hu, J. Mellor, J. Wu, C. DeLisi, VisANT: An online visualization and analysis tool for biological interaction data. BMC Bioinformatics 5, 17 (2004).
60. W. R. Swindell, A. Johnston, J. J. Voorhees, J. T. Elder, J. E. Gudjonsson, Dissecting the psoriasis transcriptome: Inflammatory- and cytokine-driven gene expression in lesions from 163 patients. BMC Genomics 14, 527 (2013).
61. M. Wheelwright, E. W. Kim, M. S. Inkeles, A. De Leon, M. Pellegrini, S. R. Krutzik, P. T. Liu, Alltrans retinoic acid-riggered antimicrobial activity against Mycobacterium tuberculosis is dependent on NPC2. J. Immunol. 192, 2280-2290 (2014).
62. A. N. Martinez, R. Lahiri, T. L. Pittman, D. Scollard, R. Truman, M. O. Moraes, D. L. Williams, Molecular determination of Mycobacterium leprae viability by use of real-time PCR. J. Clin. Microbiol. 47, 2124-2130 (2009).
63. P. T. Liu, M. Wheelwright, R. Teles, E. Komisopoulou, K. Edfeldt, B. Ferguson, M. D. Mehta, A. Vazirnia, T. H. Rea, E. N. Sarno, T. G. Graeber, R. L. Modlin, MicroRNA-21 targets the vitamin D-dependent antimicrobial pathway in leprosy. Nat. Med. 18, 267-273 (2012).
64. J. C. Oliveros, VENNY. An interactive tool for comparing lists with Venn Diagrams; http://bioinfogp.cnb.csic.es/tools/venny/index.html (2007).